Étude de cas

Leveraging Local Insights to Drive COVID-19 Vaccine Uptake in Njombe, Tanzania

Like many regions in Tanzania, Njombe had implemented numerous strategies and investment to accelerate acceptance and uptake of the COVID-19 vaccine. The first two national campaigns resulted in low vaccine uptake in Njombe region, as did subsequent efforts by implementing partners to promote vaccination through music, theater, and other health communication approaches.

As part of the Vaccination Action Network (VAN), this group set an audacious goal – to increase COVID-19 vaccination rates from 17% to 40% by leveraging local expertise and collaborative problem-solving.

Langues

  • Anglais

Année de publication

2022

Éditeur

Vaccination Action Network

Type

Étude de cas

Catégories

  • Prestation de services

Maladies

  • COVID-19

Pays

  • Tanzanie

Mots-clés

  • Demand

Régions de l'OMS

  • Région africaine

Références sur le sujet

COMPENDIUM-OTHER

TitreAuteurAnnéeTypeLangue
Cote d'Ivoire_A People-Centered Flexible Approach to COVID-19 VaccinationVillageReach2023Case studyAnglais
Demand Generation at COVID-19 Vaccination Sites in Cote d’Ivoire and Democratic Republic of CongoVillageReach2023Case studyAnglais
Improving COVID-19 Vaccine Demand with Trusted, Community-Based Vaccinators, MalawiFred Mwandida, Vaccination Action Network2022Case studyAnglais
Integrating COVID-19 Vaccination into Routine Immunization & Service Delivery, TanzaniaDr. Mwanahamisi Hassan, Regional Administration COVID-19 and Global Fund Coordinator Tanzania, Vaccination Action Network2022Case studyAnglais
Leveraging Local Insights to Drive COVID-19 Vaccine Uptake in Njombe, TanzaniaSamson SOro Sasi, Njombe Region Health Promotion lead, Tanzania, Vaccination Action Network2022Case studyAnglais
Moonlight Community Cinema to Combat Low Risk Perception of COVID-19 in Makueni County, KenyaBretta Vilia Nutisya, Vaccination Action Network2022Case studyAnglais
The Power of Religious Leaders to Drive COVID-19 Vaccine Demand ZanzibarAbdulhamid Ameir Saleh, Vaccination Action Network2022Case studyAnglais